hm-atif-wafik

US Buying World Stock of Remdesivir

The United States has bought up almost all of the world's stocks for the next three months of one of the two drugs proven to work against coronavirus, leaving none for the rest of the world.

Experts and campaigners are alarmed both by the US unilateral action on remdesivir and the wider implications, for instance in the event of a vaccine becoming available, the Guardian reports.

President Donald Trump's administration has already shown that it is prepared to outbid other countries to secure the medical supplies it needs for the US.

Dr Andrew Hill, a senior visiting fellow at Liverpool University said the US has "got access to most of the drug supply of remdesivir, so there's nothing for Europe."

It has now bought more than 500,000 doses, which is all of the manufacturer Gilead’s production for July and 90 per cent of its output for August and September. The drug is the first to be licensed in the US for the treatment of coronavirus.

Meanwhile, in the UK Prime Minister Boris Johnson will face scrutiny from MPs in the Commons at Prime Minister's Questions over the Leicester lockdown as a result of a spike in cases.

The government's been criticised by the city's mayor for its poor communications as all but essential shops are closed and the lockdown easing taking place throughout England on Saturday with the reopening of pubs, restaurants and hairdressers, will not happen there.

Labour leader Sir Keir Starmer has said people in Leicester were “crying out” for answers and suggested the government should have moved quicker.

The British Medical Association echoed these calls and said the government needs to be more "open and transparent with local Covid-19 data" and over how spikes in cases will be dealt with in the future.

Subscribe Shampratik Deshkal Youtube Channel

Comments

Shampratik Deshkal Epaper

Logo

Address: 10/22 Iqbal Road, Block A, Mohammadpur, Dhaka-1207

© 2024 Shampratik Deshkal All Rights Reserved. Design & Developed By Root Soft Bangladesh